MediciNova(MNOV) - 2025 Q2 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-33185 MEDICINOVA, INC. (Exact name of registrant as specified in its charter) Delaware 33-0927979 (State or Other Jurisdiction of Incorporation or Organization) 4275 Executive Square, Suite 300 La Jolla, CA 92037 (Address of Principal Executive Offices) (Zip Code) FORM 10-Q (Mark One) ☒ Q ...